24 September, 2021 | News
Vision Zero Cancer and Genomic Medicine Sweden (GMS) join forces with SciLifeLab, public sector authorities, regions, healthcare, academia, industry and patient organizations to create an innovation milieu that facilitates the introduction of more precise prevention...
16 September, 2021 | Press release
The Swedish national infrastructure Genomic Medicine Sweden (GMS) will receive an additional SEK 220 million investment. The investment will facilitate the continued introduction of precision medicine into Swedish healthcare, so that every individual in Sweden has...